Search results
Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda
Reuters via Yahoo Finance· 5 days ago(Reuters) -Merck & Co on Thursday raised its annual profit and revenue forecasts on the back of...
Merck Stock Climbs After Higher-Than-Expected Sales of Cancer Drug Keytruda
The Wall Street Journal· 5 days agoShares of U.S. drugmaker Merck are up nearly 4% in recent trading after the company said its...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks· 6 days agoFree Report) reported adjusted earnings of $2.07 per share for first-quarter 2024, beating the Zacks Consensus Estimate of $1.94. Earnings rose 48% year over year on a reported basis and 54% ...
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
Benzinga via Yahoo Finance· 5 days agoOn Thursday, U.S. drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter sales of $15.8...
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
WSAU Wausau· 5 days agoBy Patrick Wingrove (Reuters) - Merck & Co on Thursday raised its annual profit and revenue forecast...
Merck and Bristol-Myers Squibb are bracing to lose their most lucrative patents
Quartz· 5 days agoBoth companies reported quarterly earning Thursday, providing insights into how the drug...
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC· 5 days agoMerck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as...
Merck Beats on Earnings a Month After Major Drug Approval. The Stock Is Rising.
Barrons.com· 5 days agoFEATURE Sales of Merck ‘s blockbuster cancer drug Keytruda jumped 20% in the first quarter of the...
Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat
Investor's Business Daily· 5 days agoMerck stock popped Thursday after the Dow Jones stalwart topped Wall Street's first-quarter views on...
Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
Market Watch· 5 days agoMerck & Co. Inc. on Thursday reported first-quarter results that beat analysts’ expectations amid...